Related Experiment Videos
Abstract:
Results with pivampicillin, a new ampicillin with complete gastric absorption and capable of producing high tissue levels, in the prevention and treatment of postoperative infection in 31 cases are presented. The antibiotic was effective in 29 cases, 4 of which had a prior history of antibiotic intractability. Side-effects consisted of slight gastric disturbances, with suspension of treatment in 1 case only. No clinically significant changes in the laboratory data were noted.
Insights
Pivampicillin, a new ampicillin derivative, demonstrated high effectiveness in preventing and treating postoperative infections, with minimal side effects. This new antibiotic offers a promising option for surgical patients requiring infection management.
Area of Science:
- Pharmacology
- Infectious Diseases
- Surgical Infections
Context:
- Postoperative infections pose a significant risk to patient recovery.
- Developing effective prophylactic and therapeutic strategies is crucial in surgical settings.
- Evaluating novel antibiotic agents for improved absorption and tissue penetration is an ongoing need.
Purpose:
- To evaluate the efficacy and safety of pivampicillin in preventing and treating postoperative infections.
- To assess the clinical outcomes in patients receiving pivampicillin for surgical site infections.
- To determine the incidence and nature of side effects associated with pivampicillin use.
Summary:
- Pivampicillin, an ampicillin prodrug with complete gastric absorption and high tissue levels, was studied in 31 cases for postoperative infection prevention and treatment.
- The antibiotic proved effective in 29 cases, including 4 with previously intractable infections.
- Adverse effects were limited to mild gastric disturbances in one patient, with no significant laboratory abnormalities.
Impact:
- Pivampicillin shows significant potential as an effective agent for managing postoperative infections.
- Its favorable absorption and tissue distribution profile may enhance treatment outcomes.
- The low incidence of side effects suggests a good safety profile for clinical use.